Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gestalt Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Gestalt Diagnostics

Gestalt Diagnostics

Seed

Gestalt Diagnostics: Transforming anatomic pathology labs with automated, digital workflow solutions.

HQ
Spokane, WA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Gestalt Diagnostics, founded in Washington, is dedicated to revolutionizing anatomic pathology laboratories by transitioning from traditional glass slides and microscopes to a fully automated, digital workflow. Their core mission is to enhance the speed and accuracy of disease diagnosis through their flagship product, PathFlow®. This enterprise solution aims to streamline pathology workflows, ultimately improving patient outcomes by reducing diagnostic turnaround times.

Notable figures associated with Gestalt Diagnostics include key healthcare and technology experts who have driven the company's innovative solutions. The company has garnered attention from investors focused on healthcare advancements. Gestalt Diagnostics' significant achievements include the successful implementation of digital pathology solutions in various labs, contributing to faster and more accurate diagnoses. Their impact is evident in the improved efficiency and effectiveness of pathology services, benefiting both healthcare providers and patients.

Gestalt Diagnostics - Similar Companies

Histolix logo

Histolix

histolix.com

VistaPath Biosystems logo

VistaPath Biosystems

vistapath.ai

Proscia logo

Proscia

proscia.com

Pathology Watch logo

Pathology Watch

pathologywatch.com

Gopath Laboratories logo

Gopath Laboratories

Pathware logo

Pathware

pathware.com

Ad Path Labs logo

Ad Path Labs

rebiz.com

Instadiagnostics logo

Instadiagnostics

Bold Diagnostics logo

Bold Diagnostics

LabQ Diagnostics logo

LabQ Diagnostics

labq.com

Burst Diagnostics logo

Burst Diagnostics

burst-dx.com

Empowered Diagnostics logo

Empowered Diagnostics

PathGroup logo

PathGroup

Gregor Diagnostics logo

Gregor Diagnostics

Digital Diagnostics logo

Digital Diagnostics

Gestalt Diagnostics - Quick Facts

Who are Gestalt Diagnostics' competitors?

Companies similar to Gestalt Diagnostics include Histolix, VistaPath Biosystems, Proscia and Pathology Watch.

When was Gestalt Diagnostics founded?

Gestalt Diagnostics was founded in 2015.

Where is Gestalt Diagnostics' headquarters located?

Gestalt Diagnostics' headquarters is located in Spokane, WA, US.

When was Gestalt Diagnostics' last funding round?

Gestalt Diagnostics' most recent funding round was for $2M (USD) in April 2021.

How much has Gestalt Diagnostics raised to-date?

As of Apr 15, 2021, Gestalt Diagnostics has raised a total of $4.6M (USD).

How many employees does Gestalt Diagnostics have?

Gestalt Diagnostics has 39 employees as of Feb 5, 2024.

Gestalt Diagnostics - Classification

Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Healthcare
  • Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software